ZINBRYTA

Biogen Canada Inc🇨🇦 Health Canada

Approval Id: 11e768ce29e51524
Drug Approval Canada Name: ZINBRYTA
Product Name: ZINBRYTA
Status: Cancelled Post Market
Status Date: 2018-04-30
Original Market Date: 2017-03-30
Din: 02459620
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 92:20.00
Atc Original: L04AC01 DACLIZUMAB
Atc Name: l 04 ac 01
Aig Number: 0158650001
Company Name: Biogen Canada Inc
Company Address: 3300 Bloor Street West, West Tower, Suite 1200, Toronto, Ontario, Canada, M8X 2X2

DACLIZUMAB BETA

150 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

11e768ce29e51524

Type

Standard